Characteristics | Number of Patients (n) | Percentage |
---|---|---|
Tumor-localization | ||
ācentral | 53 | 26.2% |
āperipheral | 149 | 73.8% |
Histology | ||
āadenocarcinoma | 117 | 57.4% |
āSCCa | 75 | 36.8% |
āothers | 12 | 5.9% |
Grading | ||
In situ | 2 | 1% |
āG1 | 25 | 12.4% |
āG2 | 95 | 47.0% |
āG3 | 68 | 33.3% |
āG4 | 12 | 5.9% |
pT-category | ||
pTis | 2 | 1% |
pT1 | 90 | 45.1% |
āpT1a | 10 | 4.9% |
āpT1b | 37 | 18.1% |
āpT1c | 43 | 21.1% |
pT2 | 44 | 26.5 |
āpT2a | 39 | 19.1% |
āpT2b | 15 | 7.4% |
pT3 | 35 | 17.2% |
pT4 | 23 | 11.3 |
pN-category | ||
āpN0 | 126 | 61.8% |
āpN1 | 33 | 16.2% |
āpN2 | 45 | 22% |
pM-category | ||
āpM0 | 193 | 94.5% |
āpM1a | 5 | 2.5% |
āpM1b | 5 | 2.5% |
āpM1c | 1 | 0.5% |
āL-Status | Ā | Ā |
āL0 | 57 | 28.1% |
āL1 | 146 | 71.9% |
āV-Status | Ā | Ā |
āV0 | 165 | 81.3% |
āV1 | 38 | 18.7% |